Neonatal screening for severe combined immune deficiency.

Area of Science:

• Immunology
• Genetics
• Pediatrics

Background:

• Severe combined immunodeficiency (SCID) is a serious genetic disorder affecting the immune system.
• Early diagnosis and treatment are critical for improving outcomes in SCID patients.

Purpose of the Study:

• To review the rationale for including SCID in newborn screening programs.
• To outline current advancements and challenges in universal SCID screening.

Main Methods:

• Review of existing literature on SCID screening.
• Evaluation of T cell receptor excision circles (TRECs) as a screening biomarker.
• Discussion of proposed and emerging screening methodologies.

Main Results:

• SCID is treatable with hematopoietic stem cell transplantation, with outcomes improving significantly with early intervention.
• Universal newborn screening can facilitate prompt diagnosis and timely treatment.
• TREC quantitation on dried blood spots is a viable screening method, with other tests under evaluation.

Conclusions:

• Newborn screening for SCID is progressing towards implementation in pilot programs.
• Successful screening requires integrated systems for testing, diagnosis, treatment, and outcome tracking.